Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand.

Rattanaumpawan, Pinyo; Jirajariyavej, Supunnee; Lerdlamyong, Kanokorn; Palavutitotai, Nattawan; Saiyarin, Jatuporn

Rattanaumpawan, Pinyo; Jirajariyavej, Supunnee; Lerdlamyong, Kanokorn; Palavutitotai, Nattawan; Saiyarin, Jatuporn.

Afiliação

Rattanaumpawan P; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Jirajariyavej S; Internal Medicine Unit, Taksin Hospital, Bangkok 10600, Thailand.
Lerdlamyong K; Internal Medicine Unit, Vachira Phuket Hospital, Phuket 83000, Thailand.
Palavutitotai N; Internal Medicine Unit, Lerdsin Hospital, Bangkok 10500, Thailand.
Saiyarin J; Internal Medicine Unit, Central Hospital, Bangkok 10100, Thailand.

Antibiotics (Basel) ; 11(6)2022 Jun 15.

Article em En | MEDLINE | ID: mdl-35740211

Palavras-chave

COVID-19; favipiravir; pneumonia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google